The Germany cardiovascular devices market size is expected to expand at a high CAGR of more than 5.6% during the forecast period, 2021–2028. Growth of the market is attributed to technological advancement and the increasing cardiovascular diseases and popularity of minimally invasive surgery.
Cardiovascular disease is a disease that affects the structure and function of organs related to heart and its prevalence is increasing dramatically. With regard to cardiovascular diseases such as peripheral arterial occlusive disease coronary artery disease, congenital heart disease, and lung disease the focus has shifted to preventive health care. Cardiovascular diseases are diagnosed with the help of cardiovascular devices which are used to control, prevent, diagnose, and treat cardiovascular or heart diseases.
The report on the Germany cardiovascular devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|Report Title||Germany Cardiovascular Devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast|
|Segmentation||Device Types (Diagnostic and Monitoring Devices [Electrocardiogram (ECG), Remote Cardiac Monitoring, and Others] and Therapeutics and Surgical Devices [Cardiac Assist Devices, Cardiac Rhythm Management Devices, Catheter, Grafts, Stents, Heart Valves, and Others]), and End-Users (Hospitals, Ambulatory Surgery Centers, Clinics, and Others)|
|Report Coverage||Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast|
|Key Players Covered in the Report||Boston Scientific Corporation; Edwards Lifesciences; Abbott Laboratories; Medtronic PLC; and Cardinal Health Inc.|
Based on types of devices, the cardiovascular devices market is bifurcated into diagnostic & monitoring devices and therapeutics & surgical devices. The diagnostics and monitoring segment is further sub-segmented into electrocardiogram (ECG), remote cardiac monitoring, and others. The therapeutics and surgical device segment is further sub-segmented into cardiac assist devices, cardiac rhythm management devices, catheter, grafts, stents, heart valves, and others. The electrocardiogram segment is expected to represent a key share of the market during the forecast period. This is a common painless test used to detect heart problems and monitor your health.
Due to the increasing incidence of cardiovascular diseases that require electrocardiogram monitoring, portable compact electrocardiograms are becoming popular, especially in the field of home health care by introducing wireless ECG. It helps to monitor the patient’s condition in time and perform remote diagnosis. Therefore, Growing demand for minimally invasive surgery and technological advancement is expected to drive the market during the forecast period.
Based on end-users, the cardiovascular devices market is fragmented into hospitals, ambulatory surgery centers, clinics, and others. The hospital segment is expected to represent a key share of the market during the forecast period. The hospital segment is expected to represent a key share of the market during the forecast period. Factors such as rising incidence of CVD, increasing number of patient visits to hospitals for diagnosis, rising number of cardiac implant operations, and availability of payment for these treatments drives the market.
The Germany cardiovascular devices market has been segmented on the basis of
Key players competing in the cardiovascular devices market include Boston Scientific Corporation, Edwards Lifesciences, Abbott Laboratories, Medtronic PLC, and Cardinal Health Inc.
Some of these players are using several market strategies including/such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
Some other reports from this category!